How much revenue did DNA Chip Research generate this year?
DNA Chip Research has achieved a revenue of 490.46 M JPY this year.
DNA Chip Research Revenue 2024
DNA Chip Research Revenue
490.46 M JPY
Ticker
2397.T
ISIN
JP3548590003
In 2024, DNA Chip Research's sales reached 490.46 M JPY, a 49.74% difference from the 327.54 M JPY sales recorded in the previous year.
The DNA Chip Research Revenue history
| YEAR | REVENUE (undefined JPY) | GROSS MARGIN (%) |
|---|---|---|
| 2024 | 0.49 | 13,53 |
| 2023 | 0.33 | -10,86 |
| 2022 | 0.43 | 20,85 |
| 2021 | 0.32 | 20,40 |
| 2020 | 0.36 | 24,79 |
| 2019 | 0.36 | 27,68 |
| 2018 | 0.36 | 32,27 |
| 2017 | 0.32 | 18,75 |
| 2016 | 0.28 | -1,17 |
| 2015 | 0.36 | 13,16 |
| 2014 | 0.35 | 28,07 |
| 2013 | 0.37 | 16,21 |
| 2012 | 0.4 | 16,63 |
| 2011 | 0.59 | 20,65 |
| 2010 | 0.73 | 3,48 |
| 2009 | 0.87 | -2,18 |
| 2008 | 0.88 | -7,91 |
| 2007 | 0.79 | -9,71 |
| 2006 | 0.76 | -4,57 |
| 2005 | 1.15 | 30,02 |
DNA Chip Research Revenue, EBIT, Net Income JP3548590003 ·
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into DNA Chip Research, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by DNA Chip Research from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects DNA Chip Research’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of DNA Chip Research. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into DNA Chip Research’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing DNA Chip Research’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on DNA Chip Research’s growth potential.
DNA Chip Research Revenue, Profit, and EBIT History
| Date | DNA Chip Research Revenue | DNA Chip Research EBIT | DNA Chip Research Net Income |
|---|---|---|---|
| 2024 | 490.46 M undefined | -258.22 M undefined | -248.29 M undefined |
| 2023 | 327.54 M undefined | -362.89 M undefined | -362.34 M undefined |
| 2022 | 427.94 M undefined | -166.61 M undefined | -134.05 M undefined |
| 2021 | 324.5 M undefined | -172.2 M undefined | -172.47 M undefined |
| 2020 | 361.71 M undefined | -123.32 M undefined | -128.09 M undefined |
| 2019 | 360.81 M undefined | -99.53 M undefined | -104.88 M undefined |
| 2018 | 362.84 M undefined | -125.03 M undefined | -127.58 M undefined |
| 2017 | 324.65 M undefined | -152.56 M undefined | -211.91 M undefined |
| 2016 | 284.16 M undefined | -178.84 M undefined | -203.07 M undefined |
| 2015 | 357.32 M undefined | -99.43 M undefined | -135.92 M undefined |
| 2014 | 349.1 M undefined | -44.8 M undefined | -45.8 M undefined |
| 2013 | 371.9 M undefined | -89.9 M undefined | -80.8 M undefined |
| 2012 | 401.1 M undefined | -165.3 M undefined | -165.6 M undefined |
| 2011 | 593.6 M undefined | -153.7 M undefined | -155.2 M undefined |
| 2010 | 726.7 M undefined | -205.7 M undefined | -204.1 M undefined |
| 2009 | 873 M undefined | -288.4 M undefined | -340.2 M undefined |
| 2008 | 879.4 M undefined | -340.4 M undefined | -345.6 M undefined |
| 2007 | 787.1 M undefined | -335.3 M undefined | -410.8 M undefined |
| 2006 | 759.9 M undefined | -264.3 M undefined | -272.4 M undefined |
| 2005 | 1.15 B undefined | 87.7 M undefined | 54.8 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 1.15 B JPY | 87.7 M JPY | 54.8 M JPY |
| 2006 | 759.9 M JPY | -264.3 M JPY | -272.4 M JPY |
| 2007 | 787.1 M JPY | -335.3 M JPY | -410.8 M JPY |
| 2008 | 879.4 M JPY | -340.4 M JPY | -345.6 M JPY |
| 2009 | 873 M JPY | -288.4 M JPY | -340.2 M JPY |
| 2010 | 726.7 M JPY | -205.7 M JPY | -204.1 M JPY |
| 2011 | 593.6 M JPY | -153.7 M JPY | -155.2 M JPY |
| 2012 | 401.1 M JPY | -165.3 M JPY | -165.6 M JPY |
| 2013 | 371.9 M JPY | -89.9 M JPY | -80.8 M JPY |
| 2014 | 349.1 M JPY | -44.8 M JPY | -45.8 M JPY |
| 2015 | 357.32 M JPY | -99.43 M JPY | -135.92 M JPY |
| 2016 | 284.16 M JPY | -178.84 M JPY | -203.07 M JPY |
| 2017 | 324.65 M JPY | -152.56 M JPY | -211.91 M JPY |
| 2018 | 362.84 M JPY | -125.03 M JPY | -127.58 M JPY |
| 2019 | 360.81 M JPY | -99.53 M JPY | -104.88 M JPY |
| 2020 | 361.71 M JPY | -123.32 M JPY | -128.09 M JPY |
| 2021 | 324.5 M JPY | -172.2 M JPY | -172.47 M JPY |
| 2022 | 427.94 M JPY | -166.61 M JPY | -134.05 M JPY |
| 2023 | 327.54 M JPY | -362.89 M JPY | -362.34 M JPY |
| 2024 | 490.46 M JPY | -258.22 M JPY | -248.29 M JPY |
DNA Chip Research stock margins JP3548590003 ·
The DNA Chip Research margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DNA Chip Research. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DNA Chip Research.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the DNA Chip Research's sales revenue. A higher gross margin percentage indicates that the DNA Chip Research retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the DNA Chip Research's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the DNA Chip Research's total revenue generated. When comparing the revenue margin year over year, investors can gauge the DNA Chip Research's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the DNA Chip Research. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the DNA Chip Research's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
DNA Chip Research Margin History
| DNA Chip Research Gross margin | DNA Chip Research Profit margin | DNA Chip Research EBIT margin | DNA Chip Research Profit margin |
|---|---|---|---|
| 2024 | 13.53 % | -52.65 % | -50.62 % |
| 2023 | -10.86 % | -110.79 % | -110.63 % |
| 2022 | 20.85 % | -38.93 % | -31.32 % |
| 2021 | 20.4 % | -53.06 % | -53.15 % |
| 2020 | 24.79 % | -34.09 % | -35.41 % |
| 2019 | 27.68 % | -27.59 % | -29.07 % |
| 2018 | 32.27 % | -34.46 % | -35.16 % |
| 2017 | 18.75 % | -46.99 % | -65.27 % |
| 2016 | -1.17 % | -62.94 % | -71.46 % |
| 2015 | 13.16 % | -27.83 % | -38.04 % |
| 2014 | 28.07 % | -12.83 % | -13.12 % |
| 2013 | 16.21 % | -24.17 % | -21.73 % |
| 2012 | 16.63 % | -41.21 % | -41.29 % |
| 2011 | 20.65 % | -25.89 % | -26.15 % |
| 2010 | 3.48 % | -28.31 % | -28.09 % |
| 2009 | -2.18 % | -33.04 % | -38.97 % |
| 2008 | -7.91 % | -38.71 % | -39.3 % |
| 2007 | -9.71 % | -42.6 % | -52.19 % |
| 2006 | -4.57 % | -34.78 % | -35.85 % |
| 2005 | 30.02 % | 7.66 % | 4.78 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 30.02 % | 7.66 % | 4.78 % |
| 2006 | -4.57 % | -34.78 % | -35.85 % |
| 2007 | -9.71 % | -42.6 % | -52.19 % |
| 2008 | -7.91 % | -38.71 % | -39.3 % |
| 2009 | -2.18 % | -33.04 % | -38.97 % |
| 2010 | 3.48 % | -28.31 % | -28.09 % |
| 2011 | 20.65 % | -25.89 % | -26.15 % |
| 2012 | 16.63 % | -41.21 % | -41.29 % |
| 2013 | 16.21 % | -24.17 % | -21.73 % |
| 2014 | 28.07 % | -12.83 % | -13.12 % |
| 2015 | 13.16 % | -27.83 % | -38.04 % |
| 2016 | -1.17 % | -62.94 % | -71.46 % |
| 2017 | 18.75 % | -46.99 % | -65.27 % |
| 2018 | 32.27 % | -34.46 % | -35.16 % |
| 2019 | 27.68 % | -27.59 % | -29.07 % |
| 2020 | 24.79 % | -34.09 % | -35.41 % |
| 2021 | 20.4 % | -53.06 % | -53.15 % |
| 2022 | 20.85 % | -38.93 % | -31.32 % |
| 2023 | -10.86 % | -110.79 % | -110.63 % |
| 2024 | 13.53 % | -52.65 % | -50.62 % |
DNA Chip Research Aktienanalyse
What does DNA Chip Research do?
DNA Chip Research ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding DNA Chip Research's Sales Figures
The sales figures of DNA Chip Research originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing DNA Chip Research’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize DNA Chip Research's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in DNA Chip Research’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about DNA Chip Research Stock
How much was the turnover of the company DNA Chip Research compared to the previous year?
The revenue of DNA Chip Research has increased by 49.74% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of DNA Chip Research?
The revenue of DNA Chip Research is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of DNA Chip Research measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of DNA Chip Research so important for investors?
The revenue of DNA Chip Research is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does DNA Chip Research pay?
Over the past 12 months, DNA Chip Research paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DNA Chip Research is expected to pay a dividend of 0 JPY.
What is the dividend yield of DNA Chip Research?
The current dividend yield of DNA Chip Research is .
When does DNA Chip Research pay dividends?
DNA Chip Research pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of DNA Chip Research?
DNA Chip Research paid dividends every year for the past 0 years.
What is the dividend of DNA Chip Research?
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
In which sector is DNA Chip Research located?
DNA Chip Research is assigned to the 'Health' sector.
Wann musste ich die Aktien von DNA Chip Research kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of DNA Chip Research from 6/14/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 6/14/2024.
When did DNA Chip Research pay the last dividend?
The last dividend was paid out on 6/14/2024.
What was the dividend of DNA Chip Research in the year 2023?
In the year 2023, DNA Chip Research distributed 0 JPY as dividends.
In which currency does DNA Chip Research pay out the dividend?
The dividends of DNA Chip Research are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von DNA Chip Research
Our stock analysis for DNA Chip Research Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DNA Chip Research Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- DNA Chip Research Revenue
- DNA Chip Research Net Income
- DNA Chip Research P/E
- DNA Chip Research P/S
- DNA Chip Research EBIT
- DNA Chip Research Dividend
- DNA Chip Research Stocks
- DNA Chip Research Market capitalization
- DNA Chip Research Debt
- DNA Chip Research Liabilities
- DNA Chip Research Equity
- DNA Chip Research AAQS
- DNA Chip Research Employees
- DNA Chip Research ROE
- DNA Chip Research ROA
- DNA Chip Research ROCE